Serves as outside counsel to the South Carolina State Ports Authority (SCSPA), the fourth busiest container port in North America. In that capacity, we have counseled the SCSPA in connection with a variety of matters, including: land use and zoning issues arising out of the construction and operation of containerized and break bulk cargo terminals; land use, right-of-way acquisition, business, finance and political issues relating to the $650 million design and construction of the Cooper River Bridges Replacement Project; environmental impact, permitting, landlord-tenant/licensing issues associated with the SCSPA’s acquisition and use of the former Charleston Naval Base from the United States Government and the South Carolina Redevelopment Authority; nuclear, security and other regulatory issues associated with marine cargo being transported through the Port of Charleston, South Carolina; traditional and alternative methods of project and capital asset finance, state and federal grants, loans and funding mechanisms; local, state and federal governmental regulations; and dispute resolution in connection with procurement challenges and major commercial contract disputes.

Charleston Int'l. Ports, LLC v. S.C. State Ports Authority, No. 02-01973 (D.S.C. filed June 7, 2002).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Appellate litigation services on a notable press rights decision
Led the appellate effort on a notable press rights decision for a large media company, where a federal, common law right was recognized to shield more
Dickies Industrial Services Inc. v. Liberty Mutual Insurance Co., et al.
Represented Dickies Manufacturing Co., at the time the largest privately-owned apparel company in the United States, in an environmental coverage more
Acquisition of marine cargo handling company
Represented a global market-leading company in its acquisition of Swedish group (bulk handling systems for terminal and self-unloading ship more
Patent reexamination for Prometheus Laboratories Inc.
Represented Prometheus Laboratories, Inc. owner of an Orange Book listed branded drug, Lotronex (alosetron hydrochloride), indicated for women with more